NCI-H838 [H838]（人肺癌細胞）*

Cell Biology

Designations:

NCI-H838 [H838]

Depositors:

AF Gazdar
JD Minna

Biosafety Level:

1

Shipped:

frozen

Medium & Serum:

See Propagation

Growth Properties:

adherent

Organism:

Homo sapiens （human）

Organ: lung
Disease: adenocarcinoma; non-small cell lung cancer
Tumor stage: stage 3B
Derived from metastatic site: lymph node

In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. A. Gazdar and Dr. J. Minna and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. ephone （214） 699-8056, （214） 688-7233.

Amelogenin: X
CSF1PO: 10
D13S317: 8
D16S539: 9,12
D5S818: 11
D7S820: 9
THO1: 7
TPOX: 8,11
vWA: 17

59 years

male

Caucasian

The line was established in October 1984.
The patient was a smoker.
80 pack years.

ATCC complete growth medium: RPMI 1640 medium, 90%; fetal bovine serum, 10%

Culture medium, 95%; DMSO, 5%

23570: NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996